Signadori Bio

CARISMA Therapeutics

This company develops engineered macrophage and monocyte cell therapies to treat patients with solid tumours and liver fibrosis.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.

Waypoint Bio

This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.

Siren Bio

This company develops immuno-gene therapies combining viral gene delivery and cytokine immunotherapy to treat solid tumours for cancer patients.

Carisma Theraputics

The company develops engineered macrophage and monocyte cell therapies for patients with solid tumours, liver fibrosis and other serious diseases.

Mondego Bio

This biotechnology company develops PTPN2 inhibitors and small-molecule therapies to treat solid tumours for patients requiring cancer immunotherapies.

CellmAbs

This biotech company develops monoclonal antibodies and adoptive cell therapies to treat oncology patients with solid tumours.

DualTPharma

This company develops bacteria-based drug delivery systems to transport immunotherapies into solid tumours for cancer patients.